Work

Repurposing Pyramax®, quinacrine and tilorone as treatments for Ebola virus disease

Year: 2020

Type: article

Source: Antiviral Research

DOI: 10.1016/j.antiviral.2020.104908

Authors: Thomas R. Lane, Julie Dyall, Luke Mercer, Caleb Goodin, Daniel H. Foil, Huanying Zhou, Elena Postnikova, Janie Y. Liang, Michael R. Holbrook, Peter B. Madrid, Sean Ekins

Institutions: Collaborations Pharmaceuticals (United States), National Institutes of Health, National Institute of Allergy and Infectious Diseases, SRI International

Language: English

Topic: Viral Infections and Outbreaks Research

Subfield: Infectious Diseases

Field: Medicine

Domain: Health Sciences

SDG: Good health and well-being

Open Access status: green

Funders: U.S. Department of Health and Human Services, Battelle, National Institutes of Health, National Institute of General Medical Sciences, National Institute of Allergy and Infectious Diseases, National Institute of Environmental Health Sciences, National Center for Advancing Translational Sciences, NHLBI Division of Intramural Research

Awards: Centralized assay datasets for modelling support of small drug discovery organizations, G2410313054, Repurposing pyronaridine as a treatment for the Ebola virus, Centralized assay datasets for modelling support of small drug discovery organizations, G3804967477, G3980900660, G485454578, G5668307781, G8408629418, MegaTox for analyzing and visualizing data across different screening systems, G9000213775

OpenAlex ID: W3049001669

FWCI: 0.635

Cites: 66

Cited by: 30

Related to: 10